AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
EZRA

Reliance Global Group Inc. Common Stock (EZRA) fair value

Financial Services · Insurance Brokers · NASDAQ · United States
$2.18-4.60%
Market cap $4MUpdated Oct 24, 2026
Our verdict
Trades 50% below our fair value
Price
$2.18
Model fair valueConfidence: low
about $4.38
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Treated as a loss-making company. None of the usual models had enough data, so this uses Net asset value instead.
ACCE opinionReliance Global Group Inc. Common Stock (EZRA)
Fair value
Not available
ACCE price target
$2.30
Rating
Not rated
Horizon
12 months
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Price used: $2.18 at the close on 23 Oct 2026, 22:00 CEST.
Models: Net asset value.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
19
out of 100
P/E
0.0x
forward 0.0x
1-year return
-93.7%
Dividend yield
0.00%

Reliance Global Group Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Reliance Global Group is a small insurance brokerage that sells personal lines and commercial insurance through a network of agencies, and it has been pushing into a software-led model that tries to put quotes and policy servicing on a platform. The case for a closer look rests mostly on that platform strategy and the low equity value of the business, which trades at roughly $4M in market capitalization. The numbers, though, currently point the other way: revenue is down 31.6%, gross margin is negative at -20.0%, operating margin is -86.4%, and return on equity is -123.5%, so the company is losing money on its core activity rather than just growing slowly. With a score of 19/100 and no index membership, this is a turnaround that has not yet shown evidence of working, and it does not merit a deeper look unless management can show revenue stabilising and gross margin turning positive.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • severe
    Cash burn exceeds market cap
    Free cash flow was -$3.11M against a $4M market cap, with operating margin at -86.4% and net margin at -54.3%. The business is losing money at a rate that could outrun its equity value.
  • high
    Revenue shrinking sharply
    Revenue fell 31.6% year over year, reversing an 11.2% five-year CAGR. Gross margin is negative at -20.0%, so each sale loses money before overhead.
  • moderate
    Heavy insider selling, no buys
    Insiders disclosed $0.09M in sales across the last ten filings and no purchases, while holding 20.7% of shares. Small in dollar terms, but no insider buying offsets it.

AI research notes

AI-assisted·How I use AIWritten Oct 19, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Five-year average revenue growth of 11.2% a year shows the business has expanded for much of the past half decade.
  • The company carries modest debt, with debt to equity of 0.35, so lenders are not the main pressure point today.
  • At $2.28 the shares sit just below the ACCE price target of $2.30, which is 5.2% below, so the stock is priced close to our own target.
Why it could disappoint
  • Revenue fell 31.6% year over year, a sharp reversal from its five-year growth trend.
  • Net margin of -54.3% and ROE of -123.5% show the company is losing a large share of what it sells and earns.
  • The diluted share count rose 441.4% last fiscal year, heavily diluting existing shareholders' stakes.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where EZRA's valuation models land
Price
$2.18
Model fair valueConfidence: low
about $4.38
Model
Fair value
Upside
Net asset value
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-4.4%
1 month
-19.0%
3 months
+1.4%
6 months
-71.3%
YTD
-89.3%
1 year
-93.7%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
15 Oct 2026, 00:00 CESTACCE price target$2.30first publication$2.30

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full EZRA page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth7Value23Quality27Momentum17Total19
Valuation
Trailing P/E
0.0x
Forward P/E
0.0x
PEG
no data
P/B
0.33x
EV / Revenue
0.6x
Book value/sh
$8.10
Enterprise value
$7M
Profitability
ROE
-123.5%
FCF yield
-81.03%
ROIC
-65.9%
Health and risk
Debt / equity
0.35
Dividend yield
0.00%
Beta
0.29

Price

-94.4% · 1Y

Ask anything about EZRA

Answered from Reliance Global Group Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 0.0x0.0xhigh 7.4x
ROEbetter than 0% of peers
low -123%-123%high 10%
Div yieldbetter than 100% of peers
low 0.0%0.0%high 0.0%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
EZRA Reliance Global Group Inc. Common Stock$2.18----123.5%2719
ZBAO Zhibao Technology Inc. Class A Ordinary Shares$0.42----99.7%3447
EHTH eHealth Inc. Common Stock$0.53---2.9%5436
HUIZ Huize Holding Limited American Depositary Shares$2.14--7.4x5.3%4751
SLQT SelectQuote Inc. Common Stock$0.31---10.2%4741
AIFU AIFU Inc. Class A Ordinary Share$10.77----112.3%5634
XHG XChange TEC.INC American Depositary Shares $3.79--0.0x0.0%1656

Sector report card

Where EZRA ranks against its sector peers on each metric.

Computing percentiles…
  • GlobeNewswire•Oct 5, 2026
    Reliance Global Group Becomes Debt Free Following Retirement of 100% of Its Term Debt
  • GlobeNewswire•Oct 1, 2026
    Reliance Global Group Completes Sale of Altruis Benefit Consulting for $8 Million in Cash Plus Up to $1 Million Earnout
  • GlobeNewswire•Sep 14, 2026
    Reliance Global Group Completes Sale of Southwestern Montana Insurance Center for $2.625 Million in Cash at Closing Plus Uncapped Earnout
15 more press releases · full archive on Investor+.INVESTOR
40 filings
October 2026
Oct 23
8-KCurrent reportPeriod 2026-09-23
View on SEC →
Oct 13
8-KCurrent reportPeriod 2026-10-05
View on SEC →
Oct 5
8-KCurrent reportPeriod 2026-10-01
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR